New pill aims to loosen MS Patients' tight muscles
NCT ID NCT05179577
Summary
This study is testing whether a new, once-daily extended-release tablet called arbaclofen ER can safely reduce muscle stiffness (spasticity) in people with multiple sclerosis. About 442 adults with MS will take either the real medication or a placebo pill for several months to see which works better. The main goal is to see if the drug improves muscle flexibility and reduces stiffness compared to the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPASTICITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.